AIVITA Biomedical

March 4, 2019

Phase 2 Trial Completes Dosing First OC Patient with Aivita’s Cell Therapy

News

A Phase 2 trial exploring Aivita Biomedical’s cell therapy AVOVA-1 for ovarian cancer has treated its first patient and continues to recruit participants across eight sites in the United States. So far, ... Read more

September 26, 2018

AIVITA Doses First 10 Ovarian Cancer Patients with Cell-based Immunotherapy in Phase 2 Trial

News

The Phase 2 clinical trial evaluating AIVITA Biomedical’s cell-based immunotherapy for treating newly-diagnosed advanced ovarian cancer has dosed its first 10 patients. The study (NCT02033616) is looking to enroll 99 women at ... Read more

June 29, 2018

AIVITA Advances Phase 2 Clinical Trial for Ovarian Cancer Vaccine

News

AIVITA Biomedical has begun to randomize patients for a Phase 2 clinical trial assessing its cell-based immunotherapy for the treatment of newly-diagnosed advanced ovarian cancer. Currently recruiting participants at Hoag Memorial Hospital Presbyterian ... Read more

January 3, 2018

Aivita Launches Phase 2 Trial of Dendritic Cell Immunotherapy for Ovarian Cancer

News

Aivita Biomedical has initiated a Phase 2 trial of a new kind of dendritic cell immunotherapy for certain types of ovarian cancer. The therapy uses a patient’s own dendritic cells, ... Read more